CARbon monoxidE intoxiCatiOn in Korea: Prospective Cohort (CARE CO Cohort)

Status Recruiting

Clinical Trial Summary

This prospective cohort study enrolls subjects who experience carbon monoxide (CO) poisoning. The purpose of the study is to evaluate therapeutic effects of various treatments and short and long-term outcomes in CO poisoned patients. In addition, complications of brain and heart susceptible to CO are investigated through various ways and the association between complications and the patient's prognosis is also investigated. All subjects will be regularly monitored by physicians participating in this study.

Clinical Trial Description

This prospective cohort study enrolls subjects who experience CO poisoning. The purpose of the study is to evaluate therapeutic effects of various treatments, including hyperbaric oxygen therapy (HBO), therapeutic hypothermia (TH), and additional drugs, and short and long-term outcomes, such as neurocognitive sequelae or mortality, in CO poisoned patients. In addition, complications of brain and heart susceptible to CO are investigated through a variety of ways, such as magnetic resonance image (MRI), computed tomography (CT), ultrasound, and laboratory test, and the association between various complications and the patient's prognosis is also investigated. All subjects will be regularly monitored by physicians participating in this study. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04490317
Study type	Observational
Source	Wonju Severance Christian Hospital
Contact	Yong Sung Cha, MD
Phone	+82-33-741-1615
Email	emyscha@yonsei.ac.kr
Status	Recruiting
Phase
Start date	July 29, 2020
Completion date	December 2035

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT03940651` - Cardiac and Renal Biomarkers in Arthroplasty Surgery	Phase 4
Completed	`NCT01688648` - Comparison Between Lidocaine, Dexmedetomidine, and Their Combined Infusion in Subjects Undergoing Coronary Artery Bypass Graft	N/A
Completed	`NCT04794062` - Myocardial Injury and Quality of Life After COVID-19
Recruiting	`NCT04750616` - NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial	Phase 2
Recruiting	`NCT04615871` - Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19	Phase 2
Completed	`NCT05691764` - Effect of Cyclosporine and Remote Ischemic Preconditioning in Reperfusion Ischemia Injury on Tetralogy Fallot Patients With Correction Surgery	N/A
Withdrawn	`NCT04139655` - Colchicine Prevents Myocardial Injury After Non-Cardiac Surgery Pilot Study	N/A
Completed	`NCT04436016` - PeRiOperaTivE CardioproTection With Ivabradine in Non-cardiac Surgery	Phase 4
Completed	`NCT05748691` - Switching From Cardiac Troponin I to T
Completed	`NCT03338504` - Determining the Mechanism of Myocardial Injury and Role of Coronary Disease in Type 2 Myocardial Infarction
Recruiting	`NCT03013634` - Protective Effects of Dexmedetomidine on Myocardial Injury During Liver Transplantation	N/A
Completed	`NCT00007358` - Dexamethasone Treatment for Congenital Heart Block (CHB) in Newborns With Lupus	N/A
Recruiting	`NCT05714618` - MR Evidence of Cardiac Inflammation Post-Stroke
Recruiting	`NCT04624503` - Prognostic and Clinical Impact of Cardiovascular Involvement in Patients With COVID-19
Active, not recruiting	`NCT03339180` - Cardiac Injury in Patients With Influenza
Completed	`NCT03010839` - Cardiopulmonary Protective Effects of Modified Remote Ischaemic Preconditioning in Mitral Valve Replacement Surgery	N/A
Recruiting	`NCT04743765` - HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial	N/A
Enrolling by invitation	`NCT03253835` - Cardiac Blood Flow Patterns Associated With Left Ventricular Myocardial Damage
Completed	`NCT00817791` - Preconditioning With Hyperbaric Oxygen in Cardiovascular Surgery	N/A
Completed	`NCT04149314` - The "Hypotension Prediction Index" in Patients Undergoing Lung Surgery	N/A